NYMOX PHARMACEUTICAL CORP — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
20-F/A
20FR12G
20FR12G/A
25-NSE
3
4
4/A
424B3
424B5
6-K
6-K/A
CORRESP
CT ORDER
EFFECT
F-1
F-1/A
F-3
F-3/A
NT 20-F
POS AM
SC 13D
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | FORM 6-K | 0001640334-26-000562 | Mar 27, 2026 | — |
| 6-K | FORM 6-K | 0001640334-25-001988 | Nov 7, 2025 | — |
| 6-K | FORM 6-K | 0001640334-25-001864 | Oct 22, 2025 | — |
| 6-K | FORM 6-K | 0001640334-25-001862 | Oct 22, 2025 | — |
| 6-K | FORM 6-K | 0001640334-25-001701 | Sep 23, 2025 | — |
| 20-F | FORM 20-F | 0001640334-25-000972 | Jun 3, 2025 | Dec 31, 2024 |
| 6-K | FORM 6-K | 0001640334-25-000923 | May 22, 2025 | — |
| NT 20-F | FORM 20-F | 0001640334-25-000728 | May 1, 2025 | Dec 31, 2024 |
| 6-K | FORM 6-K | 0001640334-25-000362 | Mar 11, 2025 | — |
| 6-K | FORM 6-K | 0001640334-25-000006 | Jan 2, 2025 | Sep 30, 2024 |
| 6-K | FORM 6-K | 0001640334-24-001904 | Dec 17, 2024 | — |
| 20-F | FORM 20-F | 0001640334-24-001383 | Aug 29, 2024 | Dec 31, 2023 |
| 6-K | FORM 6-K | 0001640334-24-001139 | Jul 18, 2024 | — |
| 6-K | FORM 6-K | 0001640334-24-001122 | Jul 16, 2024 | Jul 17, 2024 |
| 6-K | FORM 6-K | 0001640334-24-000763 | May 13, 2024 | — |
| 6-K | FORM 6-K | 0001640334-24-000510 | Mar 28, 2024 | — |
| 6-K | FORM 6-K | 0001640334-23-002155 | Nov 15, 2023 | Sep 30, 2023 |
| 6-K | FORM 6-K | 0001640334-23-002040 | Nov 9, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-002021 | Nov 6, 2023 | Nov 3, 2023 |
| 6-K | FORM 6-K | 0001640334-23-001964 | Oct 26, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001739 | Sep 25, 2023 | — |
| 25-NSE | — | 0001354457-23-000656 | Sep 8, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001653 | Aug 29, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001575 | Aug 14, 2023 | Jun 30, 2023 |
| 6-K | FORM 6-K | 0001640334-23-001425 | Aug 2, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001389 | Jul 31, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001360 | Jul 25, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001358 | Jul 25, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001265 | Jul 12, 2023 | — |
| 6-K | FORM 6-K | 0001640334-23-001216 | Jul 6, 2023 | Jul 5, 2023 |
| 6-K | FORM 6-K | 0001640334-23-001158 | Jun 29, 2023 | — |
| 6-K/A | FORM 6-K/A | 0001640334-23-001155 | Jun 29, 2023 | Jun 28, 2023 |
| 6-K | FORM 6-K | 0001640334-23-001135 | Jun 27, 2023 | — |
| 4/A | PRIMARY DOCUMENT | 0001729637-23-000006 | Jun 26, 2023 | Apr 25, 2023 |
| 4/A | PRIMARY DOCUMENT | 0001729637-23-000003 | May 18, 2023 | Apr 25, 2023 |
| 6-K | FORM 6-K | 0001640334-23-000844 | May 12, 2023 | Mar 31, 2023 |
| 20-F | FORM 20-F | 0001640334-23-000736 | May 2, 2023 | Dec 31, 2022 |
| NT 20-F | NT 20-F | 0001640334-23-000534 | Mar 31, 2023 | Dec 31, 2022 |
| 6-K | FORM 6-K | 0001640334-23-000029 | Jan 6, 2023 | Jan 4, 2023 |
| 6-K/A | FORM 6-K/A | 0001640334-22-002480 | Nov 16, 2022 | Nov 10, 2022 |
| 6-K/A | FORM 6-KA | 0001640334-22-002477 | Nov 16, 2022 | Sep 30, 2022 |
| 6-K | FORM 6-K | 0001640334-22-002452 | Nov 14, 2022 | Sep 30, 2022 |
| 6-K | FORM 6-K | 0001640334-22-002387 | Nov 14, 2022 | Nov 10, 2022 |
| 6-K | FORM 6-K | 0001640334-22-001775 | Aug 15, 2022 | Jun 30, 2022 |
| 6-K | FORM 6-K | 0001640334-22-001447 | Jul 8, 2022 | Jun 28, 2022 |
| 6-K | FORM 6-K | 0001640334-22-000990 | May 13, 2022 | Mar 31, 2022 |
| 4 | FORM 4 | 0001640334-22-000918 | May 6, 2022 | May 2, 2022 |
| EFFECT | — | 9999999995-22-000946 | Apr 12, 2022 | — |
| CORRESP | — | 0001640334-22-000716 | Apr 6, 2022 | — |
| UPLOAD | — | 0000000000-22-003616 | Apr 4, 2022 | — |